研究者
J-GLOBAL ID:200901010037208489   更新日: 2020年09月01日

平井 豊博

Hirai Toyohiro
所属機関・部署:
職名: 教授
研究分野 (1件): 呼吸器内科学
競争的資金等の研究課題 (1件):
  • -
論文 (279件):
  • Yasuharu Tabara, Takeshi Matsumoto, Kimihiko Murase, Kazuya Setoh, Takahisa Kawaguchi, Shinji Kosugi, Takeo Nakayama, Toyohiro Hirai, Tomoko Wakamura, Kazuo Chin, et al. Home device-monitored sleep blood pressure reflects large artery stiffness: the Nagahama study. Journal of hypertension. 2020
  • Hironobu Sunadome, Hisako Matsumoto, Ryo Tachikawa, Takeshi Matsumoto, Kiminobu Tanizawa, Toru Oga, Junya Ono, Shoichiro Ohta, Kenji Izuhara, Toyohiro Hirai, et al. Role of serum periostin in severe obstructive sleep apnea with albuminuria: an observational study. Respiratory research. 2020. 21. 1. 143-143
  • Nobuyoshi Hamao, Isao Ito, Satoshi Konishi, Naoya Tanabe, Masahiro Shirata, Issei Oi, Mitsuhiro Tsukino, Hisako Matsumoto, Yoshiro Yasutomo, Seizo Kadowaki, et al. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial. BMC pulmonary medicine. 2020. 20. 1. 160-160
  • Tomoko Funazo, Takahiro Tsuji, Hiroaki Ozasa, Koh Furugaki, Yasushi Yoshimura, Tetsuya Oguri, Hitomi Ajimizu, Yuto Yasuda, Takashi Nomizo, Yuichi Sakamori, et al. Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model. Molecular cancer therapeutics. 2020. 19. 6. 1320-1327
  • Chie Morimoto, Hisako Matsumoto, Tomoko Tajiri, Yasuhiro Gon, Reiko Ito, Shu Hashimoto, Maho Suzukawa, Ken Ohta, Kenji Izuhara, Junya Ono, et al. High serum free IL-18 is associated with decreased omalizumab efficacy: findings from a 2-year omalizumab treatment study. The Journal of asthma : official journal of the Association for the Care of Asthma. 2020. 1-10
もっと見る
MISC (174件):
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る